{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:10:31Z","timestamp":1759104631142,"version":"3.44.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ijcard.2021.05.047","type":"journal-article","created":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T11:45:32Z","timestamp":1622547932000},"page":"109-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Cardiac glycosides are not associated with increased mortality or hospitalization rates in ICD and CRT-ICD patients after adjustment for baseline-characteristics at one-year follow-up: Results from the German DEVICE registry"],"prefix":"10.1016","volume":"338","author":[{"given":"Niklas","family":"Bode","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Hochadel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dietrich","family":"Andresen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Zahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan G.","family":"Spitzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Brachmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Stellbrink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Werner","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd-Dieter","family":"Gonska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Reinke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen","family":"Senges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Eckardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2021.05.047_bb0005","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0146-2806(96)80001-6","article-title":"The use of digitalis in heart failure","volume":"21","author":"Rahimtoola","year":"1996","journal-title":"Curr. Probl. Cardiol."},{"issue":"2016","key":"10.1016\/j.ijcard.2021.05.047_bb0010","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2021.05.047_bb0015","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2021.05.047_bb0020","first-page":"157","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)","volume":"20","author":"Hindricks","year":"2020","journal-title":"Eur. Heart J."},{"year":"2019","series-title":"World Health Organization Model List of Essential Medicines, 21st List, 2019","key":"10.1016\/j.ijcard.2021.05.047_bb0025"},{"key":"10.1016\/j.ijcard.2021.05.047_bb0030","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199702203360801","article-title":"The effect of digoxin on mortality and morbidity in patients with heart failure","volume":"336","author":"Digitalis Investigation Group","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2021.05.047_bb0035","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.amjcard.2015.01.013","article-title":"Meta-analysis of digoxin use and risk of mortality in patients with atrial fibrillation","volume":"115","author":"Ouyang","year":"2015","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2021.05.047_bb0040","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/FJC.0000000000000274","article-title":"Digoxin is associated with increased all-cause mortality in patients with atrial fibrillation regardless of concomitant heart failure: a meta-analysis","volume":"66","author":"Wang","year":"2015","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ijcard.2021.05.047_bb0045","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.amjcard.2018.09.036","article-title":"Meta-analysis of effects of digoxin on survival in patients with atrial fibrillation or heart failure: an update","volume":"123","author":"Vamos","year":"2019","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2021.05.047_bb0050","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1161\/CIRCEP.114.002046","article-title":"Interaction between digoxin and dronedarone in the PALLAS trial","volume":"7","author":"Hohnloser","year":"2014","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"10.1016\/j.ijcard.2021.05.047_bb0055","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1093\/europace\/euu393","article-title":"Dronedarone and digitalis: individually reduced post-repolarization refractoriness enhances life-threatening arrhythmias","volume":"17","author":"Frommeyer","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.ijcard.2021.05.047_bb0060","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ijcard.2016.11.024","article-title":"Interactions of digitalis and class-III antiarrhythmic drugs: amiodarone versus dronedarone","volume":"228","author":"Frommeyer","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2021.05.047_bb0065","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cardiores.2005.04.022","article-title":"Proarrhythmia as a pharmacogenomic entity: a critical review and formulation of a unifying hypothesis","volume":"67","author":"Roden","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcard.2021.05.047_bb0070","first-page":"525","article-title":"Overexpression of the Na+ \/Ca2+ exchanger influences ouabain-mediated spontaneous Ca2+ activity but not positive inotropy","volume":"336","author":"B\u00f6geholz","year":"2018","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.ijcard.2021.05.047_bb0075","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/eurheartj\/ehs348","article-title":"Increased mortality among patients taking digoxin\u2013analysis from the AFFIRM study","volume":"34","author":"Whitbeck","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2021.05.047_bb0080","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/eurheartj\/eht120","article-title":"Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial","volume":"34","author":"Gheorghiade","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2021.05.047_bb0085","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1016\/j.ijcard.2013.10.040","article-title":"Digoxin significantly improves all-cause mortality in atrial fibrillation patients with severely reduced left ventricular systolic function","volume":"169","author":"Patel","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2021.05.047_bb0090","doi-asserted-by":"crossref","first-page":"h4451","DOI":"10.1136\/bmj.h4451","article-title":"Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data","volume":"351","author":"Ziff","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2021.05.047_bb0095","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.hrthm.2015.05.016","article-title":"Digoxin therapy and associated clinical outcomes in the MADIT-CRT trial","volume":"12","author":"Lee","year":"2015","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ijcard.2021.05.047_bb0100","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.amjcard.2013.12.007","article-title":"Effect of digoxin on shocks in cardiac resynchronization therapy-defibrillator patients with coronary artery disease","volume":"113","author":"Adelstein","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2021.05.047_bb0105","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/ehjcvp\/pvw008","article-title":"Effects of digitalis on mortality in a large cohort of implantable cardioverter defibrillator recipients: results of a long-term follow-up study in 1020 patients","volume":"2","author":"Erath","year":"2016","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"10.1016\/j.ijcard.2021.05.047_bb0110","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/eurheartj\/ehi687","article-title":"Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial","volume":"27","author":"Ahmed","year":"2006","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2021.05.047_bb0115","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/ejhf.1452","article-title":"Rationale and design of the DIGIT-HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double-blind, placebo-controlled study","volume":"21","author":"Bavendiek","year":"2019","journal-title":"Eur. J. Heart Fail."},{"author":"Rienstra","key":"10.1016\/j.ijcard.2021.05.047_bb0120"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527321009049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527321009049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:54:15Z","timestamp":1759092855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527321009049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":24,"alternative-id":["S0167527321009049"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2021.05.047","relation":{},"ISSN":["0167-5273"],"issn-type":[{"type":"print","value":"0167-5273"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac glycosides are not associated with increased mortality or hospitalization rates in ICD and CRT-ICD patients after adjustment for baseline-characteristics at one-year follow-up: Results from the German DEVICE registry","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2021.05.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}